Results 81 to 90 of about 300,154 (164)

Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children

The Turkish Journal of Pediatrics, 2000
Active immunization with hepatitis A vaccine has been shown to provide long-term protection against hepatitis A virus (HAV) infection. However, few data are available regarding use of the hepatitis A vaccine in children under two years of age. The
G Kanra, S S Yalçin, M Ceyhan, K Yurdakök   +3 more
doaj  

Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. [PDF]

, 1984
Monoclonal hybridoma antibodies (MAb) of defined polypeptide specificity and biological activity were used in a competition binding assay to identify antibody binding sites (epitopes) on the glycoproteins of murine hepatitis virus-4 strain JHM (MHV-4 ...
Buchmeier, MJ, Knobler, RL, Salmi, AA, Talbot, PJ   +3 more
core  

Blood Transfusions: Are They Life Saving or Transfusing Infections? [PDF]

, 2011
Introduction: There is a risk of 1 - 2 per 1000 recipients receiving contaminated blood with viral, bacterial and parasitic agents.TTI’S are the most commonly encountered complications in transfusion medicine.
Amrutha Kumari, B, Deepa, S, Venkatesha, D   +2 more
core   +1 more source

HEPATÎT E VIRUS SEROPREVALENCE IN HEMODIALYSIS PATIENTS

Turkish Journal of Nephrology, 2019
Hepatitis E virus (HEV) is considered to be the main etiological agent of enterically transmitted non A, nonB hepatitis. This form of acute hepatitis has caused epidemic outbreaks in many developing countries, and hepatitis E infections have been ...
Kuddusi CENGİZ, Esin ÖZYILKAN, Arif Mansur COŞAR, Murat GÜNAYDIN, Gülseren KESİM, Mehmet KUNDAK   +5 more
doaj  

Seroprevalence of human immuno-deficiency virus, hepatitis B virus and hepatitis C virus among eye donors

Indian Journal of Ophthalmology, 2004
Blood specimens collected at the time of enucleation of the eyes from 483 consecutive eye donors were tested for sero-markers of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV).
Mahalakshmi B, Madhavan Hajib, Pushpalatha R, Margarita S   +3 more
doaj  

SULF1/SULF2 reactivation during liver damage and tumour growth [PDF]

, 2016
A Giakoustidis, A Schulze, AP Sahota, C Bret, CL Merry, D Shukla, DC Kroy, G Xu, G Zaman, GK Dhoot, GK Dhoot, Gurtej K. Dhoot, H Barth, H Lemjabbar-Alaoui, J Lai, Joshua I. Murphy, JP Lai, JP Lai, JP Lai, JWY Tuo, K Uchimura, Kurtis Graham, L Hitchins, M Ford-Perriss, M Meyers-Needham, M Morimoto-Tomita, M Tarocchi, MT Joy, P Tátrai, R Gill, R Nawroth, RB Gill, RB Gill, RM Gill, S Ashikari-Hada, S Wang, S Wang, SD Rosen, X Ai, X Ai, Y Xu, YC Kwon   +41 more
core   +1 more source

Seroprevalence Of Hepatitis-b Virus In Mid And Far Western Region In Nepal [PDF]

, 2012
Hepatitis B is significant health problems that might involve the late sequel of liver cirrhosis and hepatocellular carcinoma. The present study aimed to know the seroprevalence of hepatitis B virus (HBV) in mid and far western region in Nepal with ...
H, S. A. (Siddiqui), M, A. (Ansari), P, S. (Singh), S, K. (Khan)   +3 more
core  

Hepatitis B/C virus co-infection in Iran: A seroepidemiological study [PDF]

, 2007
Background/aims: As hepatitis B and C virus have the same transmission routes, dual infection may occur. The aim of this study was to determine the seroprevalence of HCV in HBsAg-positive subjects.
Abdolahi, N., Besharat, S., Danesh, A., Hosseini, S.A., Jabbari, A., Joshaghani, H., Kabir, M.J., Kalavi, K., Keshtkar, A.A., Moradi, A., Roshandel, D., Roshandel, G., Sedaqat, S.M., Semnani, S.   +13 more
core  

Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B? [PDF]

Clinical and Molecular Hepatology, 2020
Hyun Woong Lee
doaj   +1 more source

Should the GBD risk factor rankings be used to guide policy?

, 2013
Cairncross, Sandy, Watts, Charlotte
core   +1 more source